Raul Rocha addressed the international competition's future in an interview three days after Fátima Bosch was crowned Miss Universe 2025 Zoey Lyttle is a Society & Culture Writer-Reporter at PEOPLE.

Streaming News James Cameron Went Off About Netflix And The Academy, And (Acclaimed) Netflix Star Joel Edgerton Just Fired Back Movies The Batman 2 Writer And Hunger Games' Josh Hutcherson Both Fired ...

Although the Miss Universe competition ended in victory for Miss Mexico Fátima Bosch, Miss Thailand Veena Praveenar Singh finished the competition with grace as the runner-up. The Thailand native has ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Whether it was the joy of seeing the pen swirl round and round to create a spiral or all the wild ...

Novo Nordisk is winding down a range of early-stage programs for liver disease, oncology and stem cells as part of the Danish Pharma’s ambitious restructuring. This morning’s third-quarter earnings ...

There is no shortage of novel, EDC-focused bags on the market. When it comes to capable, technical packs, our collective cup runneth over. The Redeye 24’s internal organization is unmatched.

If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes ...

You’ve got a PlayStation 5 and a world of ideas, but you’ve hit the console’s wall: how do you get your own custom Minecraft server running? The PS5’s Minecraft: Bedrock Edition doesn’t make joining ...

The McBee Dynasty: Real American Cowboys’ Steven McBee Jr. is pumping the brakes on past claims that the family sold their iconic Nashville home. And, according to younger brother Cole McBee, “Dad ain ...

At its core, professional wrestling is a family business in that some of the biggest stars the industry has ever seen have been born into it. Now, another second generation star is making their way ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...